Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

171
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
171

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy.

Scientific reports·2026
Same author

Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO open·2026
Same author

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026
Same author

Establishing a National SABR Service: A Model for Safe and Effective Clinical Implementation.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Reconsidering Governance Models to Strengthen Rural Healthcare.

Journal of bioethical inquiry·2025
Same journal

Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Lifting the Lid on Best Practice in a Case of Oligometastatic Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Standardisation of Imaging Surveillance for Patients With Metastatic Melanoma Stopping Immune Checkpoint Inhibitors.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial's Use of Healthcare Systems Data for Clinical Follow-Up.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Autologous Cell Therapy in Oncology: Current Landscape and Future Directions.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Proton Beam Therapy for Intracranial Germ Cell Tumors in Pediatric, Adolescent, and Young Adult Patients: A Single-Center Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
See all related articles

Related Experiment Video

Updated: Sep 18, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K

Quality Indicators and Benchmarks for Radiotherapy in Lung Cancer: A Modified Delphi Approach.

K-L Chiew1, C Donnelly2, S V Harden3

  • 1Princess Alexandra Hospital, Division of Cancer Services, Brisbane, Australia; South Western Clinical School, University of New South Wales, Liverpool, Australia.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|June 26, 2025
PubMed
Summary
This summary is machine-generated.

This study developed 29 quality indicators (QIs) and benchmarks for lung cancer radiotherapy (RT) processes. These QIs aim to standardize quality measurement and improve patient outcomes in radiation oncology.

Keywords:
Lung cancerquality indicatorsquality of careradiotherapy

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.5K

Related Experiment Videos

Last Updated: Sep 18, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.5K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Quality Improvement

Background:

  • Existing quality indicators (QIs) for lung cancer primarily focus on clinical care, with limited options for assessing radiotherapy (RT).
  • A need exists for specific, measurable QIs to evaluate the quality of RT in lung cancer treatment.

Purpose of the Study:

  • To develop a core set of quality indicators (QIs) and benchmarks for evaluating radiotherapy processes in lung cancer.
  • To address the gap in specialized QIs for lung cancer RT quality assessment.

Main Methods:

  • A modified Delphi technique involving an international expert panel of radiation oncologists was used.
  • Candidate QIs were evaluated for importance, feasibility, and benchmark acceptability through two survey rounds.
  • Consensus was defined as at least 70% agreement among respondents.

Main Results:

  • Out of 47 initial QIs, 29 reached the threshold for importance after two Delphi rounds.
  • Agreement on QI importance ranged from 71% to 97%, with 12 QIs achieving over 90% consensus.
  • All 29 QIs were deemed feasible, and 27 benchmarks were accepted.

Conclusions:

  • A core set of 29 QIs and acceptable benchmarks for lung cancer RT processes has been established.
  • These QIs offer a framework for standardized quality measurement and benchmarking in radiation oncology.
  • The developed QIs have the potential to guide quality improvement efforts and enhance patient outcomes.